Drugs / efanesoctacog alpha
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07158606 | Oct 2025 → Dec 2030 expected | hemophilia A | Versiti Blood Health | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | efanesoctacog alpha | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07158606 ↗ |